Sublethal Doxorubicin Promotes Extracellular Vesicle Biogenesis in A375 Melanoma Cells: Implications for Vesicle-Loaded TGF-β-Mediated Cancer Progression and Cardiovascular Pathophysiology
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178524 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Laura Fernanda Fernández-Fonseca und 3 weiteren Autor:innen. Beteiligte Einrichtung: Master in Biochemistry Program, Department of Chemistry, Science Faculty, Universidad Nacional deColombia, Bogotá 111321, Colombia. Hauptthemen laut MEDLINE: Doxorubicin, Extracellular Vesicles, Melanoma, Transforming Growth Factor beta. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, Colombia.
Abstract (Originalsprache)
Doxorubicin (Dox) is not a first-line treatment for melanoma due to limited antitumor efficacy and dose-dependent cardiotoxicity. However, sublethal doses may trigger adaptive cellular responses that influence tumor progression and systemic toxicity. Small extracellular vesicles (EVs) are key mediators of intercellular communication and can carry bioactive molecules that modulate both the tumor microenvironment and distant tissues. This study investigates how sublethal Dox exposure alters EV biogenesis and cargo in A375 melanoma cells and explores the potential implications for cardiovascular function. We treated human A375 melanoma cells with 10 nM dox for 96 h. EVs were isolated using differential ultracentrifugation and size exclusion chromatography. Vesicle characterization included Immunocytochemistry for CD63, CD81, CD9, Rab7 and TSG101, scanning electron microscopy (SEM) Nanoparticle Tracking Analysis (NTA), and Western blotting for CD81 and CytC. We analyzed cytokine content using cytokine membrane arrays. Guinea pig cardiomyocytes were exposed to the isolated vesicles, and mitochondrial activity was evaluated using the MTT assay. Statistical analysis included t-tests, ANOVA, Cohen’s d, and R2 and η2. Dox exposure significantly increased EV production (13.6-fold; p = 0.000014) and shifted vesicle size distribution. CD81 expression was significantly upregulated (p = 0.0083), and SEM (microscopy) confirmed enhanced vesiculation. EVs from treated cells were enriched in TGF-β (p = 0.0134), VEGF, CXCL1, CXCL12, CCL5, IL-3, IL-4, IL-10, Galectin-3, and KITLG. Cardiomyocytes exposed to these vesicles showed a 2.3-fold reduction in mitochondrial activity (p = 0.0021), an effect absent when vesicles were removed. Bioinformatic analysis linked EV cargo to pathways involved in cardiac hypertrophy, inflammation, and fibrosis. As conclusion, sublethal Doxorubicin reprograms melanoma-derived EVs by enhancing their production and enriching their cargo with profibrotic and immunomodulatory mediators. These vesicles may contribute to tumor progression and cardiovascular physiopathology, suggesting that targeting EVs could improve therapeutic outcomes in cancer and cardiovascular disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Master in Biochemistry Program, Department of Chemistry, Science Faculty, Universidad Nacional deColombia, Bogotá 111321, Colombia.
- Molecular Physiology Group, Sub-Direction of Scientific and Technological Research, Direction of Public Health Research, National Institute of Health, Bogotá 111321, Colombia.
- Department of Chemistry, Science Faculty, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
- Department of Physiological Sciences, Faculty of Medicine, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
ORCID-Profile: Laura Fernanda Fernández-Fonseca, Susana Novoa-Herrán, Adriana Umaña-Pérez, Luis Alberto Gómez-Grosso
Förderung
- National Institute of Health, Colombia
Zitieren
APA
Fernández-Fonseca, L. F., Novoa-Herrán, S., Umaña-Pérez, A., & Gómez-Grosso, L. A. (2025). Sublethal Doxorubicin Promotes Extracellular Vesicle Biogenesis in A375 Melanoma Cells: Implications for Vesicle-Loaded TGF-β-Mediated Cancer Progression and Cardiovascular Pathophysiology. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178524
Vancouver
Fernández-Fonseca LF, Novoa-Herrán S, Umaña-Pérez A, Gómez-Grosso LA. Sublethal Doxorubicin Promotes Extracellular Vesicle Biogenesis in A375 Melanoma Cells: Implications for Vesicle-Loaded TGF-β-Mediated Cancer Progression and Cardiovascular Pathophysiology. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178524
BibTeX
@article{FernndezFonseca2025,
author = {Fernández-Fonseca, Laura Fernanda and Novoa-Herrán, Susana and Umaña-Pérez, Adriana and Gómez-Grosso, Luis Alberto},
title = {Sublethal Doxorubicin Promotes Extracellular Vesicle Biogenesis in A375 Melanoma Cells: Implications for Vesicle-Loaded TGF-β-Mediated Cancer Progression and Cardiovascular Pathophysiology},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178524}
}
EUVIMED